Amedeo Smart

Free Medical Literature Service

 

Amedeo

Gynecology
  Free Subscription

Articles published in
Cancer Lett
    November 2024
  1. FIELD NR, Dickson KA, Nassif NT, Marsh DJ, et al
    SMARCA4 and SMARCA2 co-deficiency: An uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodeling.
    Cancer Lett. 2024;605:217282.
    >> Share

    October 2024
  2. NING Y, Chen Y, Tian T, Gao X, et al
    S100A7 Orchestrates Neutrophil Chemotaxis and Drives Neutrophil Extracellular Traps (NETs) Formation to Facilitate Lymph Node Metastasis in Cervical Cancer Patients.
    Cancer Lett. 2024 Oct 7:217288. doi: 10.1016/j.canlet.2024.217288.
    >> Share

    September 2024
  3. LEWIS F, Beirne J, Henderson B, Norris L, et al
    Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma.
    Cancer Lett. 2024 Sep 26:217279. doi: 10.1016/j.canlet.2024.217279.
    >> Share

    August 2024
  4. WU H, Sun C, Cao W, Teng Q, et al
    Blockade of the lncRNA-PART1-PHB2 axis confers resistance to PARP inhibitor and promotes cellular senescence in ovarian cancer.
    Cancer Lett. 2024;602:217192.
    >> Share

    July 2024
  5. JAISWAL SK, Fedkenheuer K, Khamar R, Tan H, et al
    The Megacomplex protects ER-alpha from degradation by Fulvestrant in epithelial ovarian cancer.
    Cancer Lett. 2024 Jul 22:217129. doi: 10.1016/j.canlet.2024.217129.
    >> Share

  6. XU J, Lu W, Wei X, Zhang B, et al
    Single-cell transcriptomics reveals the aggressive landscape of high-grade serous carcinoma and therapeutic targets in tumor microenvironment.
    Cancer Lett. 2024;593:216928.
    >> Share

    June 2024
  7. FENG X, Ji Z, Fan X, Kong Y, et al
    ASS1 Enhances Anoikis Resistance via AMPK/CPT1A-mediated Fatty Acid Metabolism in Ovarian Cancer.
    Cancer Lett. 2024 Jun 22:217082. doi: 10.1016/j.canlet.2024.217082.
    >> Share

  8. MENG H, Miao H, Zhang Y, Chen T, et al
    YBX1 promotes homologous recombination and resistance to platinum-induced stress in ovarian cancer by recognizing m5C modification.
    Cancer Lett. 2024 Jun 14:217064. doi: 10.1016/j.canlet.2024.217064.
    >> Share

  9. YU Y, Lyu C, Li X, Yang L, et al
    Remodeling of tumor microenvironment by extracellular matrix protein 1a differentially regulates ovarian cancer metastasis.
    Cancer Lett. 2024;596:217022.
    >> Share

    April 2024
  10. HA JH, Radhakrishnan R, Nadhan R, Gomathinayagam R, et al
    Deciphering a GPCR-lncRNA-miRNA Nexus: Identification of an Aberrant Therapeutic Target in Ovarian Cancer.
    Cancer Lett. 2024 Apr 18:216891. doi: 10.1016/j.canlet.2024.216891.
    >> Share

  11. KAUR P, Shankar E, Gupta S
    EZH2-mediated development of therapeutic resistance in cancer.
    Cancer Lett. 2024;586:216706.
    >> Share

    March 2024
  12. PONGRATANAKUL P, Bremmer F, Pauls S, Poschmann G, et al
    Assessing the risk to develop a growing teratoma syndrome based on molecular and epigenetic subtyping as well as novel secreted biomarkers.
    Cancer Lett. 2024;585:216673.
    >> Share

  13. CAO C, Xu Q, Zhu Z, Xu M, et al
    Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer.
    Cancer Lett. 2024 Mar 10:216809. doi: 10.1016/j.canlet.2024.216809.
    >> Share

    February 2024
  14. LIU J, Liu C, Ma Y, Pan X, et al
    STING inhibitors sensitize platinum chemotherapy in ovarian cancer by inhibiting the CGAS-STING pathway in cancer-associated fibroblasts (CAFs).
    Cancer Lett. 2024 Feb 17:216700. doi: 10.1016/j.canlet.2024.216700.
    >> Share

    January 2024
  15. AO K, Yin M, Lyu X, Xiao Y, et al
    METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer.
    Cancer Lett. 2024 Jan 20:216658. doi: 10.1016/j.canlet.2024.216658.
    >> Share

  16. MEI X, Xiong J, Liu J, Huang A, et al
    DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4/PI3K/AKT axis and VEGF-C secretion.
    Cancer Lett. 2024 Jan 9:216609. doi: 10.1016/j.canlet.2024.216609.
    >> Share

    December 2023
  17. LIN CL, Ying TH, Yang SF, Lin CL, et al
    Magnolin targeting of the JNK/Sp1/MMP15 signaling axis suppresses cervical cancer microenvironment and metastasis via microbiota modulation.
    Cancer Lett. 2023 Dec 18:216584. doi: 10.1016/j.canlet.2023.216584.
    >> Share

    November 2023
  18. NAMKAEW J, Zhang J, Yamakawa N, Hamada Y, et al
    Repositioning of mifepristone as an integrated stress response activator to potentiate cisplatin efficacy in non-small cell lung cancer.
    Cancer Lett. 2023 Nov 28:216509. doi: 10.1016/j.canlet.2023.216509.
    >> Share

  19. GARG V, Kumar L
    Metronomic chemotherapy in ovarian cancer.
    Cancer Lett. 2023 Nov 1:216469. doi: 10.1016/j.canlet.2023.216469.
    >> Share

    October 2023
  20. CHEN L, Zheng X, Liu W, Sun Y, et al
    Compound AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR-EZH2 interaction and enhances the efficacy of tazemetostat in endometrial cancer.
    Cancer Lett. 2023 Oct 20:216445. doi: 10.1016/j.canlet.2023.216445.
    >> Share

  21. DOGRA S, Elayapillai SP, Qu D, Pitts K, et al
    Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer.
    Cancer Lett. 2023 Oct 12:216437. doi: 10.1016/j.canlet.2023.216437.
    >> Share

    September 2023
  22. YUE S, Wang Q, Zhang J, Hu Q, et al
    Understanding cervical cancer at single-cell resolution.
    Cancer Lett. 2023 Sep 26:216408. doi: 10.1016/j.canlet.2023.216408.
    >> Share

  23. VENKATA PP, Jayamohan S, He Y, Alejo S, et al
    Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer.
    Cancer Lett. 2023 Sep 13:216383. doi: 10.1016/j.canlet.2023.216383.
    >> Share

    August 2023
  24. ZHANG X, Guo H, Chen J, Xu C, et al
    Highly proliferative and hypodifferentiated CAR-T cells targeting B7-H3 enhance antitumor activity against ovarian and triple-negative breast cancers.
    Cancer Lett. 2023 Aug 17:216355. doi: 10.1016/j.canlet.2023.216355.
    >> Share

    July 2023
  25. BERTAGNIN C, Messa L, Pavan M, Celegato M, et al
    A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells.
    Cancer Lett. 2023 Jul 31:216331. doi: 10.1016/j.canlet.2023.216331.
    >> Share

  26. POOREBRAHIM M, Quiros-Fernandez I, Marme F, Burdach SE, et al
    A costimulatory chimeric antigen receptor targeting TROP2 enhances the cytotoxicity of NK cells expressing a T cell receptor reactive to human papillomavirus type 16 E7.
    Cancer Lett. 2023;566:216242.
    >> Share

  27. CHEN X, Zhou J, Li X, Wang X, et al
    Corrigendum to "Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype" [Cancer Lett. 435 (28 October 2018) 80-91].
    Cancer Lett. 2023 Jul 8:216292. doi: 10.1016/j.canlet.2023.216292.
    >> Share

    May 2023
  28. SHAO Y, Li H, Wu Y, Wang X, et al
    The feedback loop of AURKA/DDX5/TMEM147-AS1/let-7 drives lipophagy to induce cisplatin resistance in epithelial ovarian cancer.
    Cancer Lett. 2023;565:216241.
    >> Share

    April 2023
  29. MOSKOVICH D, Alfandari A, Finkelshtein Y, Weisz A, et al
    Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233].
    Cancer Lett. 2023;563:216196.
    >> Share

    January 2023
  30. ZHANG Y, Qiu JG, Jia XY, Ke Y, et al
    METTL3-mediated N6-methyladenosine modification and HDAC5/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance.
    Cancer Lett. 2023;553:215971.
    >> Share

  31. JIANG W, Ouyang X, Ji Z, Shi W, et al
    The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer.
    Cancer Lett. 2023;556:216064.
    >> Share

  32. HOLLIS RL
    Molecular characteristics and clinical behaviour of epithelial ovarian cancers.
    Cancer Lett. 2023;555:216057.
    >> Share

    September 2022
  33. ZHANG YR, Zheng PS
    NEK2 inactivates the Hippo pathway to advance the proliferation of cervical cancer cells by cooperating with STRIPAK complexes.
    Cancer Lett. 2022 Sep 14:215917. doi: 10.1016/j.canlet.2022.215917.
    >> Share

    August 2022
  34. XIANG T, Du L, Pham P, Zhu B, et al
    Corrigendum to "Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathway" [Cancer Letters 364 (2015) 79-88].
    Cancer Lett. 2022 Aug 25:215895. doi: 10.1016/j.canlet.2022.215895.
    >> Share

    June 2022
  35. RUSSO A, Zizhao Y, Heyrman GM, Cain BP, et al
    Versican secreted by the ovary links ovulation and migration in fallopian tube derived serous cancer.
    Cancer Lett. 2022 Jun 10:215779. doi: 10.1016/j.canlet.2022.215779.
    >> Share

    May 2022
  36. WANG W, Jo H, Park S, Kim H, et al
    Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer.
    Cancer Lett. 2022 May 12:215735. doi: 10.1016/j.canlet.2022.215735.
    >> Share

    April 2022
  37. ZHAO Z, Shuang T, Gao Y, Lu F, et al
    Targeted delivery of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization.
    Cancer Lett. 2022;530:45-58.
    >> Share

    January 2022
  38. SOTO-GAMEZ A, Wang Y, Zhou X, Seras L, et al
    Enhanced extrinsic apoptosis of therapy-induced senescent cancer cells using a death receptor 5 (DR5) selective agonist.
    Cancer Lett. 2022;525:67-75.
    >> Share

  39. DU S, Qian J, Tan S, Li W, et al
    Tumor cell-derived exosomes deliver TIE2 protein to macrophages to promote angiogenesis in cervical cancer.
    Cancer Lett. 2022;529:168-179.
    >> Share

  40. HERNANDEZ I, Cohen M
    Linking cell-surface GRP78 to cancer: From basic research to clinical value of GRP78 antibodies.
    Cancer Lett. 2022;524:1-14.
    >> Share

    December 2021
  41. ZHAN L, Zhang J, Zhang J, Liu X, et al
    LC3 and NLRC5 interaction inhibits NLRC5-mediated MHC class I antigen presentation pathway in endometrial cancer.
    Cancer Lett. 2021;529:37-52.
    >> Share

  42. QIAO HY, Zhang Q, Wang JM, Jiang JY, et al
    TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer.
    Cancer Lett. 2021;529:85-99.
    >> Share

  43. SALINAS-MONTALVO AM, Supramaniam A, McMillan NA, Idris A, et al
    RNA-based gene targeting therapies for human papillomavirus driven cancers.
    Cancer Lett. 2021;523:111-120.
    >> Share

  44. LIU C, Huang Y, Qin T, You L, et al
    AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway.
    Cancer Lett. 2021 Dec 20. pii: S0304-3835(21)00638.
    >> Share

    November 2021
  45. SUN D, Qin Z, Xu Y, Xiao Q, et al
    The IVF-generated human embryonic microenvironment reverses progestin resistance in endometrial cancer cells by inducing cancer stem cell differentiation.
    Cancer Lett. 2021 Nov 11. pii: S0304-3835(21)00569.
    >> Share

  46. PIN F, Prideaux M, Huot JR, Essex AL, et al
    Non-bone metastatic cancers promote osteocyte-induced bone destruction.
    Cancer Lett. 2021;520:80-90.
    >> Share

    October 2021
  47. ZHAO S, Huang L, Basu P, Domingo EJ, et al
    Cervical cancer burden, status of implementation and challenges of cervical cancer screening in Association of Southeast Asian Nations (ASEAN) countries.
    Cancer Lett. 2021;525:22-32.
    >> Share

  48. VENKATA PP, Chen Y, Alejo S, He Y, et al
    KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer.
    Cancer Lett. 2021;524:219-231.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016